不同BMI患者在HRT-FET周期转化日子宫内膜厚度阈值及最佳内膜厚度区间分析

来源 :中华生殖与避孕杂志 | 被引量 : 0次 | 上传用户:caacmis487
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨不同体质量指数(body mass index,BMI)人群中转化日子宫内膜厚度(endometrial thickness,EMT)对激素替代治疗-冻融胚胎移植(hormone replacement frozen-thawed embryo transfer,HRT-FET)临床结局的影响,并分析达到理想临床妊娠率时对应的最佳EMT和EMT区间。方法:回顾性队列研究分析2013年1月至2017年12月期间在河南省人民医院生殖医学中心行激素替代周期HRT-FET准备子宫内膜的10 239个周期,根据BMI分为低体质量组(BMI<18.5 kg/mn 2)、正常体质量组(BMI=18.5~24.9 kg/㎡)、超重组(BMI=25.0~29.9 kg/mn 2)和肥胖组(BMI≥30.0 kg/mn 2),每组再根据EMT分为4个亚组:EMT<8.0 mm、8.0 mm≤EMT<10.0 mm、10.0 mm≤EMT0.05);正常体质量组及超重组各亚组间,随着EMT的增加临床妊娠率及活产率均增加明显(正常体质量组各亚组均n P<0.001,超重组各亚组n P=0.123、n P=0.009、n P=0.016;均n P<0.001);肥胖组各亚组间随EMT增加,临床妊娠率增加不明显(n P=0.449,n P=0.279),当EMT≥12.0 mm时,增加明显(n P=0.021),活产率增加明显,差异有统计学意义(n P=0.014,n P=0.005,n P<0.001)。②曲线拟合结果显示,正常体质量组及超重组EMT对临床妊娠率及活产率的影响均呈曲线关系,即随EMT增加,临床妊娠率先明显上升,后增速变缓并高水平维持,再有下降趋势;低体质量组及肥胖组EMT对临床妊娠率及活产率的影响呈直线关系。③根据曲线拟合,正常体质量组及超重组进行阈值效应分析,正常体质量组EMT对临床妊娠率及活产率影响的内膜拐点为10.0 mm,EMT低于10.0 mm时,其每增加1.0 mm,临床妊娠率提高20%(n OR=1.20,95% n CI=1.13~1.26),活产率提高19%(n OR=1.19,95% n CI=1.13~1.26);超重组EMT对临床妊娠率及活产率的拐点也为10.0 mm,低于10.0 mm时,其每增加1.0 mm,临床妊娠率提高24%(n OR=1.24,95% n CI=1.13~1.26),活产率提高26%(n OR=1.26,95% n CI=1.14~1.40)。EMT超过拐点时,随EMT增加临床妊娠率及活产率增幅不明显。n 结论:正常体质量组及超重组EMT分别在10.0~13.5/10.0~12.7 mm、10.0~14.0/10.0~12.5 mm区间时临床妊娠率及活产率最佳,子宫内膜过薄或者过厚均影响临床妊娠结局。低体质量组及肥胖组EMT对临床妊娠率及活产率影响呈直线关系,但有待进一步研究。“,”Objective:To investigate the effect of endometrial thickness (EMT) on the clinical outcome of hormone replacement frozen-thawed embryo transfer (HRT-FET) cycle in different body mass index (BMI) groups, and to analyze the threshold and optimal EMT and EMT interval corresponding to the ideal clinical pregnancy rate.Methods:A retrospective cohort study was conducted on 10 239 HRT-FET cycles in the Reproductive Medicine Center of Henan Provincial People\'s Hospital from January 2013 to December 2017, and they were divided into low weight group (BMI<18.5 kg/mn 2), normal weight group (BMI=18.5-24.9 kg/mn 2), overweight group (BMI=25.0-29.9 kg/mn 2) and obese group (BMI≥30.0 kg/mn 2). Four subgroups were divided according to EMT, respectively EMT<8.0 mm, 8.0 mm≤EMT<10.0 mm, 10.0 mm≤EMT0.05). The clinical pregnancy rate and the live birth rate increased with the increase of EMT between subgroups of normal body weight group and super-recombinant subgroups (alln P<0.001 for normal body weight subgroups,n P=0.123, n P=0.009, n P=0.016 and all n P<0.001 for super-recombinant subgroups). In the obesity group, with the increase of EMT, the clinical pregnancy rate did not increase significantly except EMT≥12.0 mm subgroup (n P=0.449, n P=0.279, n P=0.021), while the live birth rate increased significantly (n P=0.014, n P=0.005, n P<0.001). 2) Curve fitting showed that in the population of low weight and obese, influence of EMT on clinical pregnancy rate was a straight line, in the population of normal weight and overweight, influence of EMT on clinical pregnancy rate was a curve, as EMT increased the clinical pregnancy rate raised and then decreased, the impact on the live birth rate appeared similar. 3) According to the curve fitting, the threshold effect analysis of the normal weight group showed that the endometrial inflection point of EMT on the clinical pregnancy rate and the live birth rate was 10.0 mm. When EMT was lower than 10.0 mm, the clinical pregnancy rate and the live birth rate increased by 20% and 19% for every 1.0 mm increase in endometrial thickness (n OR=1.20, 95% n CI=1.13-1.26; n OR=1.13,95% n CI=1.13-1.26). In overweight group, the inflection point of EMT on the clinical pregnancy rate and the live birth rate was also 10.0 mm. When EMT was lower than 10.0 mm, the clinical pregnancy rate and the live birth rate increased by 24% and 26% for every 1.0 mm increase in EMT (n OR=1.24, 95% n CI=1.13-1.26; n OR=1.26, 95% n CI=1.14-1.40). When EMT exceeded 10.0 mm, the clinical pregnancy rate and the live birth rate did not increase significantly with the increase of EMT.n Conclusion:In HRT-FET cycle, the endometrial thickness has an effect on the clinical pregnancy rate and the live birth rate in the normal weight group and the overweight group. The clinical pregnancy rate and the live birth rate were the best when the EMT was between 10.0-13.5/10.0-12.7 mm and 10.0-14.0/10.0-12.5 mm, respectively. Whether the endometrium was too thin or too thick would affect the clinical pregnancy outcome. The influence of EMT on clinical pregnancy rate and live birth rate was linear between the low weight group and the obese group, but further study is needed.
其他文献
Polo样激酶1(Polo-like kinase 1,PLK1)是丝氨酸/苏氨酸蛋白激酶家族成员之一。在有丝分裂中,PLK1参与控制中心体成熟、染色体凝聚、动粒-微管附着和胞质分裂。在哺乳动物卵母细胞减数分裂中PLK1也具有与在有丝分裂中类似的功能,但尚缺少PLK1在卵母细胞减数分裂调节机制方面的系统性的文献综述报道。本文从PLK1在卵母细胞减数分裂各时期的定位情况,及其在卵母细胞染色体凝聚、微管组织中心解聚、γ-微管蛋白和中心粒周蛋白的募集以及后期促进复合物/细胞周期体(anaphase-promot
目的:探讨不同体质量指数(body mass index,BMI)对多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者体外受精-胚胎移植(n in vitro fertilization and embryo transfer,IVF-ET)临床结局的影响。n 方法:回顾性队列研究分析2016年1月至2018年12月期间在郑州大学第一附属医院生殖医学中心就诊的年龄<35岁首次行IVF-ET助孕并采用卵泡期长效长方案的患者临床资料,共2982例,其中PCOS
目的:探讨miR-152通过靶向成纤维细胞生长因子2(FGF2)对肺癌A549细胞系的增殖和侵袭的作用机制.方法:通过实时荧光定量PCR(qPCR)检测正常上皮细胞BEAS-2B和肺癌A549细胞中miR-152和FGF2的表达情况;采用转染技术,分别特异性表达肺癌A549细胞系中miR-152和FGF2基因的表达.将肺癌A549细胞系分为6组:miRNA空转组(miR-NC组)、miR-152过表达组(miR-152 mimics组)、miR-152抑制组(miR-152 inhibitor组)、FGF
目的:探讨在X射线诱发恒河猴卵巢损伤中慢性炎症是否发挥重要作用.方法:14只月经周期规律的成年雌性恒河猴(8~14岁),随机分为3组(3只/组):假照射(Sham)组(n=8)、卵巢照射(OXI)组(n=3)、X射线照射+FTY-720(免疫抑制剂)(FTY-720)组(n=3).Sham组给与溶剂PET+假手术(保留卵巢血管蒂,将卵巢移出腹腔),OXI组动物卵巢移出腹腔后给与15 Gy X射线照射,FTY-720组卵巢内行0.2 mmol/L FTY-720灌注1周后给与15 Gy X射线照射.各组手术
目的:研究伯氏疟原虫输出蛋白——红细胞膜相关蛋白1(EMAP1)在疟原虫生长发育和侵染中的作用,构建EMAP1缺失的伯氏疟原虫突变体.方法:以pL0035质粒为载体,PCR扩增EMAP1编码区上游和下游序列作为同源臂,用酶切连接和无缝克隆的方法将两条同源臂分别插入pL0035,获得重组质粒pL0035-ΔPbEMAP1;利用疟原虫转染技术在伯氏疟原虫中敲除EMAP1,有限稀释法筛选EMAP1基因敲除的单克隆虫株,PCR和Southern印迹鉴定基因型;定制抗PbEMAP1多克隆抗体,利用Western印迹
目的:研究胰胆转流(PBD)术造成的高胆囊收缩素(CCK)血症对小鼠小肠I细胞群落及胰腺细胞和胰腺消化酶含量的影响.方法:40只雄性Balb/C裸鼠随机分为PBD组及假手术(SO)组,每组20只,分别实施PBD术和假手术.20 d后称重胰腺重量,并用酶联免疫吸附法测定血浆CCK,用免疫组化法在十二指肠中测定I细胞群落,在胰腺中检测CCK受体和增殖细胞核抗原,以酶联免疫吸附法测定胰腺组织中胰蛋白酶原、脂肪酶、淀粉酶的含量.结果:PBD组血浆CCK水平高于SO组(t=16.59,P<0.01),胰腺重量也较S
目的:探讨儿童过敏性疾病血清过敏原sIgE检测的临床意义.方法:收集天津市公安医院儿科门诊就诊的过敏性疾病患儿,607例患儿应用酶联免疫吸附实验检测吸入性过敏原sIgE,其中男384例,女223例;629例患儿检测食物性过敏原sIgE,其中男383例,女246例.了解患儿静脉血吸入性和食物性过敏原sIgE的浓度,判断患儿的过敏原以及过敏程度,并进行统计学分析.结果:吸入性过敏原sIgE阳性者562例,阳性率92.6%;食物性过敏原sIgE阳性者506例,阳性率80.4%;吸入过敏原sIgE比食物过敏原sI
目的:探讨肺炎支原体肺炎(MPP)患儿外周血CD64、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)水平与血清MP-IgM抗体滴度的相关性.方法:选取天津市滨海新区塘沽妇产医院儿科收治的130例MPP确诊患儿,按照病情程度分为轻症组(76例)和重症组(54例).采集患儿外周血测定血清CD64、CK、CK-MB、LDH及MP-IgM抗体滴度.分析不同病情程度患儿的各指标测定结果,分析不同MP-IgM抗体滴度患儿的CD64、CK、CK-MB、LDH水平,并分析CD64、CK、CK-MB、
目的:分析Graves病患者合并胸腺增生的相关影响因素.方法:收集2018年11月—2020年11月临床确诊的Graves病患者100例,依据胸部CT结果分为两组:合并胸腺增生51例,未合并胸腺增生49例.分析两组年龄、病程、白细胞、中性粒细胞、肝功能、游离甲状腺功能(甲功)、促甲状腺素受体抗体(TRAb)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)等相关指标.结果:本研究中Graves病合并胸腺增生发生率为51%;Graves病合并胸腺增生组与未合并胸腺增生组相比,年龄较小,谷丙转
目的:探讨孕晚期女性家庭亲密度与适应性、基本心理需要满足与抑郁之间的关系.方法:对常规产检的327名孕晚期女性进行整体抽样调查,回收有效问卷300份,受试者平均年龄(32.11±4.51)岁,通过PHQ-9抑郁筛查量表、基本心理需要量表中文版、家庭亲密度与适应性量表中文版考察其抑郁症状、家庭亲密度、家庭适应性以及基本心理需要满足水平.结果:(1)样本人群的抑郁检出率为19.33%,孕妇的不良孕史(χ2=5.69,P=0.017)、家庭亲密度(F=4.71,P=0.003)、家庭适应性(F=3.83,P=0